Breakthroughs in Gene-Editing and Cancer Mutation Mapping

Harvard researchers have developed a new gene-editing tool called Helicase-Assisted Continuous Editing (HACE) that allows for precise mutations in specific genes without affecting the rest of the genome. By combining helicase enzymes with CRISPR technology, HACE can target and mutate specific DNA sequences, aiding in the study of gene functions and disease mechanisms. This tool has already identified mutations linked to cancer drug resistance and splicing defects in blood cancers, highlighting its potential for therapeutic discovery and advancing genomic research.